Monosodium L-glutamate-induced convulsions: temporary alteration in blood-brain barrier permeability to plasma

Environmental Physiology & Biochemistry
|January 1, 1975
PubMed

Insights

Monosodium L-glutamate (MSG) causes seizures and increased brain vascular permeability in young rats. These effects, including dye entering brain tissue, diminish with age, disappearing by 42 days.

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • Monosodium L-glutamate (MSG) is a widely used food additive.
  • MSG administration can induce neurological effects, including seizures, particularly in neonatal animals.
  • Previous studies suggest potential neurotoxic effects of MSG.

Purpose of the Study:

  • To investigate the effects of MSG on cerebrovascular permeability and seizure activity in rats.
  • To determine the age-dependency of MSG-induced neurological and vascular changes.
  • To examine the correlation between seizure activity and specific brain lesions.

Main Methods:

  • Intraperitoneal administration of MSG (4.0 g/kg) to neonatal rats.
  • Observation of seizure incidence and severity.
  • Assessment of cerebrovascular permeability using trypan blue dye.
  • Histological examination of brain tissue.

Main Results:

  • MSG induced dose-dependent convulsions and reversible increases in cerebrovascular permeability in neonatal rats.
  • Trypan blue dye penetrated brain tissue during MSG-induced seizures, indicating compromised blood-brain barrier.
  • Seizure incidence and dye penetration decreased significantly with increasing age, absent by 42 days.
  • Seizure activity was not correlated with periventricular-arcuate area lesions or hypothalamic damage.

Conclusions:

  • MSG-induced seizures and altered cerebrovascular permeability are age-dependent phenomena in rats.
  • The blood-brain barrier integrity is compromised during acute MSG intoxication in young rats.
  • MSG does not appear to cause the characteristic hypothalamic lesions in older rats, suggesting a developmental window for this toxicity.

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...